Milpitas, CA, United States of America

Kevin M Limtao

This inventor holds 12 USPTO granted patents and 5 published patent applications. Top assignees: Hound Labs, Inc., Click Diagnostics, Inc., Visby Medical, Inc.. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin M Limtao. Retrieved from https://idiyas.com/inventor/kevin-m-limtao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 69(Granted Patents)


Location History:

  • Milpitas, CA (US) (2018 - 2024)
  • Temple City, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Kevin M Limtao - Innovative Inventor from Milpitas, CA

Introduction: Kevin M Limtao is a talented inventor based in Milpitas, California, known for his groundbreaking innovations in various fields.

Latest Patents: Kevin Limtao holds several patents in the areas of technology and consumer electronics, showcasing his commitment to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Kevin Limtao has worked with leading tech companies, contributing his expertise to the development of cutting-edge products and solutions.

Collaborations: Throughout his career, Kevin Limtao has collaborated with top researchers, engineers, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Kevin M Limtao continues to inspire the next generation of inventors with his passion for innovation and his dedication to creating a better future through his groundbreaking inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…